Arcadia biosciences, inc. (RKDA)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss)

2,423

-

-

-

-12,612

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss

-

-

-

-

-

-

4,450

-6,669

-10,615

-2,960

-4,525

-4,006

-4,216

-5,708

-4,175

-4,551

-5,190

-3,857

-4,619

-3,677

-5,803

-1,988

-7,064

-5,811

-3,476

Adjustments to reconcile net income (loss) to cash used in operating activities:
Initial loss on common stock warrant and common stock adjustment feature liabilities

-

-

-

-

-

0

0

0

4,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Change in fair value of common stock warrant liabilities

-8,161

2,453

7,777

-9,482

8,495

-3,575

-8,421

535

1,900

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Offering costs

-

-

-

-

-

11

1

1,639

904

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation

74

-

-

-

34

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

-

-

-

-

-

-

25

46

52

-

69

65

81

77

80

80

67

84

69

69

72

86

89

89

94

Lease amortization

223

178

182

176

172

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss (gain) on disposal of equipment

-

-

-

-

-

0

0

0

3

-2

0

0

3

-

-

-

-

-

-

-

-

-

-

-

-

Net amortization of investment premium

39

59

39

43

39

78

88

25

2

7

17

29

36

-

-

-

-

-

-

-

-

-

-

-

-

Equity in loss of unconsolidated entity

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-536

-396

Stock-based compensation

772

417

1,059

389

422

552

342

358

298

297

417

389

371

398

268

172

221

187

281

537

387

381

196

198

201

Net amortization of investment premium and discount

-

-

-

-

-

-

-

-

-

-

-

-

-

-25

24

-63

-76

-

-

-

-

-

-

-

-

Common stock warrants issued for services

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

37

56

Change in fair value of derivative liabilities related to convertible promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-836

-263

-291

1,399

-10

819

-219

21

Accretion of debt discount

-

-

-

-

-

-

-

-

-

0

-1

50

49

50

50

50

48

248

246

202

141

126

34

158

150

Write down of inventory

59

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Accounts receivable

-293

475

2

46

-86

-28

13

128

-1,179

1,158

-359

148

-65

252

-80

-410

-119

21

540

-5

-892

984

-193

152

-550

Unbilled revenue

-

-

-

-

-

-166

62

57

45

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amounts due from related parties

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-100

Unbilled revenue

-

-

-

-

-

-

-

-

-

-

-80

29

-72

40

52

-14

24

-349

219

42

-210

-716

461

169

191

Inventories

4,145

124

850

600

-39

141

-75

-205

-21

-19

-24

-78

-62

-614

13

33

-14

-569

57

51

49

138

-1,378

404

424

Prepaid expenses and other current assets

748

-28

-269

505

-200

-183

89

382

-137

-546

-381

199

404

-307

-178

29

641

40

-51

450

-24

-

-

-

-

Other noncurrent assets

15

-

-

-

-

-

-

-

-

-256

-82

-96

423

-1

-71

-85

152

-92

-16

67

-8

-

-

-

-

Accounts payable and accrued expenses

227

-323

1,748

1,215

-538

318

-90

270

-322

583

29

-349

-176

-256

42

-219

414

-1,551

707

734

235

-276

-291

-182

533

Amounts due to related parties

-24

12

9

6

-16

10

6

8

-25

-2

4

7

-10

-

-

3

-7

4

5

-68

22

11

0

-156

5

Unearned revenue

-25

-38

65

-41

-40

39

-154

-101

-96

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease payments

-184

-181

-185

-177

-172

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Unearned revenue

-

-

-

-

-

-

-

-

-

-

-169

-312

38

492

-440

-37

200

21

-258

-448

-136

-524

-33

-280

-141

Net cash used in operating activities

-9,270

-5,012

-3,757

-4,460

-3,969

-2,695

-4,018

-4,301

-2,617

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

CASH FLOWS FROM INVESTING ACTIVITIES:
Net cash used in operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-4,530

-4,277

-3,931

-3,992

-4,855

-3,946

-4,581

-3,984

-2,598

-2,658

-3,706

-6,297

-2,126

Cost method investment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

500

250

700

Proceeds from sale of property and equipment

-

-

-

-

-

0

1

0

9

0

0

0

4

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

778

599

563

227

88

161

21

35

33

2

19

1

57

9

24

61

137

71

57

16

7

-

-

-

-

Purchases of investments

1,292

9,900

9,835

1,933

6,690

-

-

-

-

0

0

14,823

4,582

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sales and maturities of investments

15,200

3,400

4,900

3,950

9,200

15,200

5,050

0

3,900

8,880

17,993

25,090

14,695

16,068

8,042

1,740

10,465

-

-

-

-

-

-

-

-

Net cash provided by investing activities

13,130

-7,084

-5,497

1,790

2,422

8,025

1,067

-18,943

3,876

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock and warrants from purchase agreement

-

-

-

-

-

-

0

0

10,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of offering costs relating to purchase agreement

-

-

-

-

-

-

3

373

932

-

-

-

-

-

-

-

-

151

1,249

5,567

1,238

-

-

-

-

Net cash provided by investing activities

-

-

-

-

-

-

-

-

-

-

-

-

10,060

-4,197

-13,111

1,679

10,328

-34,990

-11,347

-16

-7

-108

-535

-248

-700

Payments of deferred offering costs

-

-

-

-

5

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Payments of debt issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

1

45

-

-

-

-

-

-

-

-

Principal payments on notes payable

7

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from ESPP purchases

14

-

-

-

8

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from exercise of stock options and purchases through ESPP

-

-

-

-

-

0

3

0

966

0

8

0

16

14

155

134

139

192

140

26

2

-

-

-

-

Capital contributions received from non-controlling interest

689

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used in) financing activities

696

-28

15,149

6,878

-13

-1

-47

12,493

10,034

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net increase (decrease) in cash and cash equivalents

4,556

-

-

-

-1,560

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from issuance of redeemable convertible preferred stock and common stock warrants, net of issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

31,961

884

Payments on notes payable and convertible promissory notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

23,674

0

1,670

1,452

248

241

236

359

Capital lease payments

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

20

20

19

Net cash provided by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

16

14

155

133

94

-57

-1,109

72,725

-2,688

-1,833

-264

31,705

506

Net increase in cash and cash equivalents

-

-

-

-

-

-

-

-10,751

11,293

6,195

-10,508

5,879

5,546

-8,460

-16,887

-2,180

5,567

-38,993

-17,037

68,725

-5,293

-4,599

-4,505

25,160

-2,320

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for interest

-

-

-

-

-

-

-

-

-

-

-

-

288

278

281

281

193

639

466

435

510

-

-

-

-

Cash paid for income taxes

-

0

0

0

2

10

0

0

24

-

-

-

-

27

0

1

1

0

0

1

148

-

-

-

-

Cash paid for interest

3

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

NONCASH INVESTING AND FINANCING ACTIVITIES:
Fixed assets acquired with notes payable

37

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Offering costs in accounts payable and accrued expenses at end of period

-

-1

-1

15

7

-

-

-288

334

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs in accounts payable and accrued expenses at end of period

-

-

-

-

18

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accretion of redeemable convertible preferred stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

879

1,695

-

-

-

-

Common stock warrants issued to placement agent and included in offering costs related to purchase agreement

-

-

-

-

-

-

0

0

526

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from sale of fixed assets included in prepaid expenses and other current assets at end of period

-

-

-

-

-

-

-

0

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Right of use assets obtained in exchange for new operating lease liabilities

3,836

0

0

0

2,328

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred offering costs included in accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,333

1,752

-264

-

-

-

-

Purchases of fixed assets included in accounts payable and accrued expenses

-

-5

0

-7

13

-

-

-

-

-

-

-

2

-

-

-

1

-

-

-

-

-

-

-

-

Exchange of membership interest in unconsolidated entity for common stock

-

-

-

-

-

-

-

-

-

0

0

0

2

-

-

-

-

-

-

-

-

-

-

-

-

Deemed dividends to common stock warrant holder

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

197

-

-

-

-

June 2018 Offering [Member]
Payments of offering costs

-

0

0

8

16

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-